Among patients with permanent atrial fibrillation, cognitive impairment may be more common in those with suboptimal antithrombotic therapy, oral anticoagulation, or heart rate control.
Higher cardiovascular risk burden assessed by the Framingham General Cardiovascular Risk Score is associated with cognitive decline and structural brain differences.
Neurologic conditions associated with HIV remain major contributors to morbidity and mortality, and are increasingly recognized in the aging population of individuals living with HIV.
Between the aspirin and placebo groups, there was no significant difference in the risk for all dementia triggers, probable Alzheimer disease, or mild cognitive impairment.
